Expert Shares the Top Energy Saving Tips for 2025
Reading Time: 5 minutes Energy costs are consistently on the rise, and most of us are looking desperately for ways to cut back our bills in the new year. Here are some top tips from energy expert William Hobbs at MyJobQuote.co.uk on
Heimdal and Watsoft Team Up to Strengthen MSP Cybersecurity in France
Reading Time: 2 minutes COPENHAGEN, Denmark, and PARIS, France, January 13, 2025 — Heimdal, a top European cybersecurity company, is teaming up with Watsoft, a French IT distributor focused on Managed Service Providers (MSPs). This partnership will help MSPs in France deal with today’s growing
Arctic Bioscience – funded to cash positive
Reading Time: 2 minutes Arctic Bioscience is now funded through a NOK 30 million loan facility. Strong 30% y/y growth in sales revenues in 2024 and prospects of continued strong growth in coming years. Psoriasis drug candidate HRO350 on track for 12 months readout end of
FISKARS CORPORATION: ACQUISITION OF OWN SHARES 13.01.2025
Reading Time: < 1 minute Stock Exchange Release 13.01.2025 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 13.01.2025 Date 13.01.2025 Exchange transaction Buy Share class FSKRS Amount 2000 Average price/share 14.5861 EUR Highest price/share 14.6200 EUR Lowest price/share
ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 13.01.2025
Reading Time: < 1 minute ALEXANDRIA GROUP OYJ NOTIFICATION 13.01.2025 at 18:30 EET ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 13.01.2025 Date 13.01.2025 Exchange transaction Buy Share class ALEX Amount 200 Average price/share 8,8500 EUR Highest
OncoZenge AB has entered into a non-binding agreement with the intention to partner with Molteni Farmaceutici for commercialization of BupiZenge™ in Europe
Reading Time: 3 minutes STOCKHOLM, SWEDEN – January 13, 2025 – OncoZenge AB (publ) (“OncoZenge” or the “Company”), announces that the Company has entered into a non-binding agreement with the intention to partner with pharmaceutical leader Molteni Farmaceutici (“Molteni”) regarding exclusive rights to commercialization of BupiZenge™
Arctic Bioscience – Primary insiders participating in convertible loan facility
Reading Time: 2 minutes Reference is made to the stock exchange release from earlier today, 13th January 2025, regarding new funding, including a convertible loan facility of NOK 15 million. The following primary insiders, or closely related companies to primary insiders, are a part of
disposing remaining Castellum shares to its parent
Reading Time: < 1 minute Akelius Residential Property AB has agreed to sell its remaining 51,800,760 shares in Castellum. The buyer is Akelius Apartments Limited,and the agreed price is SEK 130 per share. Akelius Residential Property AB does not hold any shares in Castellum after
Roc Oil Company Pty Limited announces the final outcome of the recommended cash offer to the shareholders of Tethys Oil AB
Reading Time: 10 minutes THIS ANNOUNCEMENT IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA OR SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT
SlotsRank Highlights the Top Global Markets for Online Slots in 2025
Reading Time: 2 minutes Stockholm, Sweden – January 2025 – SlotsRank, a renowned platform offering insights into the online gaming industry, highlights the dynamic growth of online slots across the globe in 2025. SlotsRank, a dedicated segment of CasinoRank specializing in slot games, provides additional expertise